EMBC

Embecta Sinks As Outlook Comes In Below Consensus

(RTTNews) - Shares of diabetes care company Embecta Corp. (EMBC) are falling more than 12 percent Friday morning after the company provided full-year profit outlook below the Street view.

Embecta now expects adjusted profit in the range of $1.95 - $2.15 for the full year. Analysts on average, polled by Thomson-Reuters expects the company to report earnings of $2.22 per share.

Revenue for the full year is expected in the range of $1.094 billion - $1.116 billion. This compares with the consensus estimate of $1.1 billion for the year.

EMBC is at $15.48 currently. It has traded in the range of $12.72 - $33.88 in the last 1 year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.